abstract |
The present invention relates to a novel pharmaceutical composition for the treatment of dystonia or relieving pain caused by myotonic condition in a subject suffering from dystonia. Particularly, the present invention provides a pharmaceutical composition for treating dystonia or relieving pain caused by dystonia comprising a serotonin receptor 5-HT 2A inhibitor as an active ingredient. |